Combining double fluorescence in situ hybridization with immunolabelling for detection of the expression of three genes in mouse brain sections

Journal of Visualized Experiments

Volumn 2016, Issue 109, 2016, Pages

  Jolly, Sarah ^a   Fudge, Alexander ^a   Pringle, Nigel ^a   Richardson, William D ^a   Li, Huiliang ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

ASPA; Canavan disease; Gene expression; Immunohistochemistry; In situ hybridization; Issue 109; Neuroscience; Oligodendrocytes

Indexed keywords

AMIDASE; ASPARTOACYLASE;

ANIMAL; ASTROCYTE; BRAIN; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MICROGLIA; MOUSE; NERVE CELL; OLIGODENDROGLIA; PROCEDURES;

AMIDOHYDROLASES; ANIMALS; ASTROCYTES; BRAIN; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MICE; MICROGLIA; NEURONS; OLIGODENDROGLIA;

EID: 84962394026     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/53976     Document Type: Article

References (17)

1. Lobsiger, C. S., & Cleveland, D. W. Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat Neurosci. 10 (11), 1355-1360 (2007).
2. Baslow, M. H. N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res. 28 (6), 941-953 (2003).
3. Hoshino, H., & Kubota, M. Canavan disease: clinical features and recent advances in research. Pediatr Int. 56 (4), 477-483 (2014).
4. Kaul, R., Gao, G. P., Balamurugan, K., & Matalon, R. Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease. Nat Genet. 5 (2), 118-123 (1993).
5. Divry, P., & Mathieu, M. Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease. Am J Med Genet. 32 (4), 550-551 (1989).
6. Bartalini, G. et al. Biochemical diagnosis of Canavan disease. Childs Nerv Syst. 8 (8), 468-470 (1992).
7. Moffett, J. R., Ross, B., Arun, P., Madhavarao, C. N., & Namboodiri, A. M. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol. 81 (2), 89-131 (2007).
8. D’Adamo, A. F., Jr., Smith, J. C., & Woiler, C. The occurrence of N-acetylaspartate amidohydrolase (aminoacylase II) in the developing rat. J Neurochem. 20 (4), 1275-1278 (1973).
9. Bhakoo, K. K., Craig, T. J., & Styles, P. Developmental and regional distribution of aspartoacylase in rat brain tissue. J Neurochem. 79 (1), 211-220 (2001).
10. Sommer, A., & Sass, J. O. Expression of aspartoacylase (ASPA) and Canavan disease. Gene. 505 (2), 206-210 (2012).
11. Klugmann, M. et al. Identification and distribution of aspartoacylase in the postnatal rat brain. Neuroreport. 14 (14), 1837-1840 (2003).
12. Madhavarao, C. N. et al. Immunohistochemical localization of aspartoacylase in the rat central nervous system. J Comp Neurol. 472 (3), 318-329 (2004).
13. Hershfield, J. R. et al. Aspartoacylase is a regulated nuclear-cytoplasmic enzyme. Faseb J. 20 (12), 2139-2141 (2006).
14. Moffett, J. R. et al. Extensive aspartoacylase expression in the rat central nervous system. Glia. 59 (10), 1414-1434 (2011).
15. Kirmani, B. F., Jacobowitz, D. M., Kallarakal, A. T., & Namboodiri, M. A. Aspartoacylase is restricted primarily to myelin synthesizing cells in the CNS: therapeutic implications for Canavan disease. Brain Res Mol Brain Res. 107 (2), 176-182 (2002).
16. Kirmani, B. F., Jacobowitz, D. M., & Namboodiri, M. A. Developmental increase of aspartoacylase in oligodendrocytes parallels CNS myelination. Brain Res Dev Brain Res. 140 (1), 105-115 (2003).
17. Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci. 34 (36), 11929-11947 (2014).